Although several different ADAMs have been implicated in cancer initiation and progression [28], as well as conferring resistance to specific cancer therapies in various tumour types, ADAM17 and ADAM10 remain as the two most important metalloproteases [29, 30]. This evidence concerns the gene ADAM10 and neoplasm.